INHIBITOR Therapeutics Inc. announced that Debra Peattie, PhD, MBA has been appointed as an independent member of its Board of Directors. Dr. Peattie is a veteran life science entrepreneur who previously served as Senior Director in the Future Pipelines Discovery Division of GlaxoSmithKline, where she focused on translating early-stage science into novel therapeutics within GSK's Discovery Partnerships with Academia initiative.